InvestorsHub Logo
Followers 7
Posts 269
Boards Moderated 0
Alias Born 12/04/2004

Re: None

Thursday, 12/01/2022 8:42:21 PM

Thursday, December 01, 2022 8:42:21 PM

Post# of 471241
MayoMobile
@JesseSatellite
·
33m
$AVXL just blew away amyloid-targeting results. ADAS-COG score in the entire dosed population (30+50mg cohorts) improved over 4 points which is statistically significant and clinically meaningful. CLINICALLY MEANINGFUL. #CTAD22

MayoMobile
@JesseSatellite
·
27m
Replying to
@CatbirdLit
Sure. Basically the CTAD attendees as a whole are pleased with Lecanemab data (which was good) but was not clinically meaningful. Blarcamesine was. It can make an extremely meaningful impact in a patients life. This is true disease modification.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News